Introducing Artemis.

The Scalability Revolution of Regenerative Medicine. From $30K to $300.

About

Artemis

A hyper-scalable and platform-enabled matrix for tissue engineering and regenerative medicine.

From healing skin wounds to full-scale organ biomanufacturing.

Backed by top-tier international research institutions and global healthcare partners, Asclepii aims to revolutionize the power of wound healing by incorporating brand-new drug delivery and stem cell technologies that can adapt to your body's needs.

Artemis makes it simple.

Faster on-site applications. Off-the-shelf supply chain. Iterative product pipeline that builds on top of itself.

Meet Artemis™ Alpha, our lead program

  • A collagen-enriched 3D matrix enhanced for optimal wound healing and wound bed preparation

  • Our unique technology features fast coagulation, strong antimicrobial properties, and enhanced cellular activity

  • This shelf-stable, durable extracellular matrix can be used for skin injuries, surgical sites, and biomanufacturing

Technology

  • Our unique components and manufacturing process allows for the integration of nearly any additive directly into the matrix

  • Additives can include:

    • analgesics

    • antimicrobials

    • coagulants

    • biologics

    • botanicals

    • Improved quality of care

    • No special storage requirements

    • Robust application

    • Infinitely scalable

2025

Artemis™ Alpha

The next generation of collagen dressings. Engineered for your cells to a molecular level.

2028

Artemis™ Apollo

A cell therapy so simple you could do it at home. Engineered to work with scaffolds like Artemis™

2031

Artemis™ Centauri

Scalable organ biomanufacturing so no-one has to wait for an organ transplant or donor again.

Asclepii is tackling wound care with the next generation of tissue engineering therapeutics.

Our base product is remarkably versatile; it can be used alone as a primary dressing, as a scaffold for cell and blood therapy, and for a range of wound types including burns, ulcers, and puncture wounds. 

One of our major use-cases is tackling chronic wounds like Diabetic Foot Ulcers.

It’s also a great way to push Artemisinto new horizons.

Asclepii products are developed and produced in partnership with: